Clinicopathologic Features of Sporadic Colorectal Cancers with CpG Island Methylator Phenotype

蔡国响,蔡三军,徐烨,师英强,孙孟红,陆洪芬,管祖庆,廉朋,彭俊杰,周晓燕,杜祥,施达仁

DOI: https://doi.org/10.3760/j.issn:0254-1432.2006.06.005

2006-01-01

Abstract:Objective To investigate the clinicopathologic features of sporadic colorectal cancers with CpG island methylator phenotype. Methods The methylation of the promotors of the five genes including p14, hMLH1, p16, MGMT and MINT1 were detected using methylation specific PCR in 71 patients to determine the clinicopathologic characteristics of sporadic colorectal cancers with CpG island methylator phenotype. Results Fifteen out of 71 (21. 1%) patients were positive for the CpG island methylator phenotype. The proportion of the right-sided colonic cancers(40. 0% vs. 12. 5% , P0. 05) , poorly-differentiated cancers(46. 7% vs. 14. 3% , P0. 05) , cancers with lymph node metastasis(86. 7% vs. 48.2% , P0. 05) and cancers with Dukes C or D stage (86. 7% vs. 50. 0% , P0. 05)in sporadic colorectal cancers with CpG island methylalor phenolype were significanlly higher than those without CpG island methylator phenotype. Conclusions Compared with sporadic colorectal cancers without CpG island melhylator phenolype, those with CpG island methylator phenotype tend to occur in the right hemicolon, to have poor differentiation and lymph node metastasis, and lo be in the later stages.